
FDA has no objections over BLIS M18 Probiotic GRAS status
The US Food and Drug Administration has no objections around the GRAS (Generally Recognized As Safe) status of BLIS M18, a probiotic strain for oral health.
News, Analysis & Insights on Nutrition, Supplements, and Health
The US Food and Drug Administration has no objections around the GRAS (Generally Recognized As Safe) status of BLIS M18, a probiotic strain for oral health.
A combination supplement of vitamin D plus leucine-enriched whey protein may reduce chronic low-grade inflammation in older people with sarcopenia, says a new study.
Editor's Spotlight
Read about food fortification, illegal diet pills and an 11-year-old dairy ban in India, health claims under scrutiny in Singapore, and yet more infant formula controversy plaguing Nestlé in our news regulatory round-up.
India's recently formed Expert Nutraceutical Advocacy Council (ENAC) has launched its website and named its advocacy board members as it ramps up its mission to become an independent voice for the nutrition industry in the country.
Singapore-based kombucha brand Yocha is investing in scaling up its production at a new factory in order to support its overseas expansion strategy.
A supply agreement with Fonterra will see Bubs Australia venture into the cow's milk infant formula space, though the firm has stressed that it will continue to innovate across its core range of goat's milk products.